Life Sciences & Healthcare

Amendment adopted to Czech Pharmaceuticals Act to address drug shortages

January 2024 – An amendment to the Pharmaceuticals Act has been adopted by the Czech parliament and officially published.

Cannabis use: CEE regulatory update

October 2023 – Significant changes in the regulation of cannabis use have occurred in some countries in Central and Eastern Europe since our last report.

New regulation of telemedicine in the Czech Republic

September 2023 – The Czech Republic should soon have its own legal regulation for telemedicine. A government proposal is on its way to the Parliament to introduce a basic definition of telemedicine. Until now, there has been no legal definition, which...

Czech amendment to the Medicines Act seeks to address drug shortages

June 2023 – On 14 June 2023, the Czech government approved a draft amendment to the Medicines Act. The aim is to improve the availability of medicines on the market and to mitigate the potential negative impacts of recent and ongoing medicines supply...

Current eHealth trends in CEE and Turkey

April 2023 – The healthcare industry in Central and Eastern Europe and Turkey is undergoing a digital transformation, with telemedicine at the forefront. Governments and healthcare providers are adopting digital solutions to improve medical services...

Kinstellar advises on an IFI-financed pharma sector acquisition in Uzbekistan

April 2023 – Kinstellar is delighted to announce that it has advised a holding company of a leading Ukrainian pharmaceutical company, YURiA PHARM, on the two-stage acquisition of a pharmaceutical company in Uzbekistan.

Slovak court orders public health insurance provider to pay EUR 2 million for the medicinal product Zolgensma, citing discrimination

March 2023 – Zolgensma[i] is an orphan medicinal product designated by the European Medicines Agency for the treatment of spinal muscular atrophy (“SMA”), a long-term debilitating and life-threatening disease that causes breathing difficulties and...

Czech Competition Authority's sector inquiry ends with recommendations for pharmaceutical industry

February 2023 – The Czech Competition Authority has concluded its sector inquiry into the distribution of pharmaceuticals in the Czech Republic, with a focus on the impact of direct distribution systems on competition.

Decentralized clinical trials: Current developments in CEE and Turkey

January 2023 – The rapid development of technologies and solutions in the healthcare sector is contributing to the proliferation of decentralised clinical trials (“DCTs”).  The aim of DCTs is for clinical trials to be conducted more effectively...

Žurić i Partneri Kinstellar advises OTP banka d.d. on the financing for the acquisition of Fiziodent Polyclinic

December 2022 – Our team in Croatia has once again advised OTP banka d.d., this time on the financing for the acquisition of Fiziodent Polyclinic through the sale of a majority ownership stake to Adria Dental Group.